Click on a filter below to refine your search. Remove a filter to broaden your search.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
The greatest reduction was seen for women aged 65 to 74 years who self-identify as Black.
Potential class-dependent associations may exist, however.